 |
 |
 |
|
 |
|
 |
 |
 |
 |
 |
Abacavir
|
| |||||||||||
|
| ||||||||||||
|
Abacavir
|
||||||||||||
|
| Pharmakokinetik | ||
Allgemeines |
|
|
 |
||
Bioverfügbarkeit |
83% |
|
|
||
Verteilungsvolumen |
|
|
|
||
Plasmaproteinbindung |
|
|
|
||
Liquor |
|
|
|
||
Metabolisierung |
Glukuronidierung, Carboxylierung |
|
|
||
totale Clearance |
|
|
|
||
Halbwertszeit |
1,5 h (Plasma), 3,3 h (intrazellulär) |
|
|
||
Q0 |
|
|
|
||
Elimination |
|
|
|
||
Dialysierbarkeit |
renal |
|
|
||
| ||
| ||||||||||
